Nocardia: A Novel Environmental Agent For Parkinsonism?
诺卡氏菌:帕金森病的新型环境因子?
基本信息
- 批准号:6649714
- 负责人:
- 金额:$ 34.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-08-15 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): The acid-fast bacterium
Nocardia asteroides (NA) is widespread in the environment, and subclinical
human infection is common. Experimental infection of mice with this organism
results in loss of nigrostriatal dopaminergic neurons, decreased striatal
dopamine concentration, and movement abnormalities including head shaking and
slowness of movement. These neurochemical and motor alterations are similar to
those in Parkinson's disease (PD). The long range goal of our studies is to
determine how and why neurons in the substantia nigra pars compacta (SNpc)
deteriorate in PD. The objective of this application is to determine the
relevance of NA infection as an animal model for PD and a potential causative
agent of PD. Our central hypothesis is that CNS NA infection results in the
specific loss of dopaminergic neurons and development of motor abnormalities by
mechanisms similar to those suggested for PD. This hypothesis has been
formulated on the basis of strong preliminary data, suggesting that (a)
nocardial toxicity in the SNpc is dopamine neuron-specific, (b) histological
findings, including dopamine neuron loss and development of Lewy body-like
inclusions, are similar to those in PD, and (c) some of the movement
abnormalities in these animals result from striatal dopamine depletion, because
they respond to levodopa administration. The rationale for this research is
that an understanding of the process by which experimental NA infection causes
loss of dopaminergic neurons and motor abnormalities may enhance our ability to
prevent this process in PD. Nocardia may be a cause of PD because the organism
can survive long-term in the brain as an L-form, suggesting that chronic,
subclinical infection could result in neurodegeneration. We are uniquely
qualified to perform this research because of our experience with the various
in vivo and in vitro aspects of this model. The central hypothesis will be
tested and the objective of the application accomplished by pursuing three
specific aims: (1) Determine the relationship between neurological and motor
abnormalities in mice experimentally infected with NA, and the relevance of
this model to PD, (2) Characterize the specificity and mechanism of NA
toxicity, and (3) Determine whether evidence for NA infection can be detected
in brain specimens from NA-infected mice and from human subjects with PD and
Parkinsonian-like syndromes. This work is innovative because it explores the
novel hypothesis that an infectious agent may offer a new model for PD and may
even contribute to the disease. It is our expectation that these studies will
reveal the extent to which this animal model resembles PD, as well as whether
persistent NA infection occurs in the PD brain. These outcomes will be
significant because they should add to our understanding of the
neurodegenerative process in PD, and could lead to improved means of diagnosis
and treatment for individuals with this disorder.
描述(改编自申请人摘要):耐酸细菌
星状诺卡氏菌(NA)广泛存在于环境中,
人类感染是常见的。用这种微生物感染小鼠的实验
导致黑质纹状体多巴胺能神经元的损失,
多巴胺浓度和运动异常,包括摇头和
动作缓慢。这些神经化学和运动改变类似于
帕金森病(Parkinson's Disease,PD)我们研究的长期目标是
确定黑质神经元(SNpc)如何以及为什么
在PD中恶化。本申请的目的是确定
NA感染作为PD动物模型的相关性和潜在病因
PD的代理人。我们的中心假设是CNS NA感染导致
多巴胺能神经元的特异性损失和运动异常的发展,
类似于PD的机制。这一假设一直被
根据强有力的初步数据制定,表明(a)
SNpc中的诺卡氏菌毒性是多巴胺神经元特异性的,(B)组织学
结果,包括多巴胺神经元损失和路易体样的发展,
夹杂物,是类似于那些在PD,和(c)一些运动
这些动物的异常是由于纹状体多巴胺耗竭,因为
它们对左旋多巴给药有反应。这项研究的基本原理是
对实验性NA感染导致
多巴胺能神经元的丧失和运动异常可能会增强我们的能力,
在PD中阻止这个过程。诺卡氏菌可能是PD的原因之一,因为该微生物
可以在大脑中以L型长期存活,这表明慢性,
亚临床感染可导致神经变性。我们是唯一
有资格进行这项研究,因为我们的经验与各种
in vivo体内and in vitro外aspects方面of this model模型.核心假设是
测试和应用程序的目标实现追求三个
具体目标:(1)确定神经和运动之间的关系
实验性感染NA的小鼠的异常以及与NA的相关性
(2)探讨NA的特异性和作用机制
毒性,和(3)确定是否可以检测到NA感染的证据
在来自NA感染小鼠和患有PD的人类受试者的脑标本中,
类帕金森综合征这项工作是创新的,因为它探讨了
一种新的假设,即感染因子可能为PD提供一种新的模型,
甚至会导致疾病我们希望这些研究将
揭示这种动物模型与PD相似的程度,以及是否
持续性NA感染发生在PD脑中。这些结果将是
重要的是,它们应该增加我们对
神经退行性过程中的PD,并可能导致改善诊断手段
以及对患有这种疾病的人的治疗。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nocardia asteroides-Induced movement abnormalities in mice: Relevance for Parkinson's disease?
- DOI:10.1002/mds.26711
- 发表时间:2016-08
- 期刊:
- 影响因子:0
- 作者:Loeffler DA;LeWitt PA;Camp DM
- 通讯作者:Camp DM
Comparison of PCR and culture for detection of Nocardia asteroides in brain specimens from experimentally infected BALB/c mice.
PCR 和培养物检测实验感染 BALB/c 小鼠脑标本中小行星诺卡氏菌的比较。
- DOI:10.1016/j.micres.2004.05.003
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Loeffler,DavidA;Camp,DianneM;Nichols,LihuaQu;Maksaereekul,Saipiroon;Beaman,BlaineL;LeWitt,PeterA
- 通讯作者:LeWitt,PeterA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER A LEWITT其他文献
PETER A LEWITT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER A LEWITT', 18)}}的其他基金
Southeastern Michigan Parkinson's Disease Program
密歇根州东南部帕金森病项目
- 批准号:
7013965 - 财政年份:2002
- 资助金额:
$ 34.37万 - 项目类别:
Southeastern Michigan Parkinson's Disease Program
密歇根州东南部帕金森病项目
- 批准号:
6666859 - 财政年份:2002
- 资助金额:
$ 34.37万 - 项目类别:
Southeastern Michigan Parkinson's Disease Program
密歇根州东南部帕金森病项目
- 批准号:
6545866 - 财政年份:2002
- 资助金额:
$ 34.37万 - 项目类别:
Nocardia: A Novel Environmental Agent For Parkinsonism?
诺卡氏菌:帕金森病的新型环境因子?
- 批准号:
6326525 - 财政年份:2001
- 资助金额:
$ 34.37万 - 项目类别:
Nocardia: A Novel Environmental Agent For Parkinsonism?
诺卡氏菌:帕金森病的新型环境因子?
- 批准号:
6525204 - 财政年份:2001
- 资助金额:
$ 34.37万 - 项目类别:
PARKINSON DISEASE PATHOPHYSIOLOGY--CSF MARKERS
帕金森病病理生理学--脑脊液标志物
- 批准号:
3414333 - 财政年份:1990
- 资助金额:
$ 34.37万 - 项目类别:
PARKINSON DISEASE PATHOPHYSIOLOGY--CSF MARKERS
帕金森病病理生理学--脑脊液标志物
- 批准号:
3414334 - 财政年份:1990
- 资助金额:
$ 34.37万 - 项目类别:
PARKINSON DISEASE PATHOPHYSIOLOGY--CSF MARKERS
帕金森病病理生理学--脑脊液标志物
- 批准号:
3414332 - 财政年份:1990
- 资助金额:
$ 34.37万 - 项目类别:
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 34.37万 - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 34.37万 - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
$ 34.37万 - 项目类别:
Studentship
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
$ 34.37万 - 项目类别:
Operating Grants
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
$ 34.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
$ 34.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
- 批准号:
22KJ2095 - 财政年份:2023
- 资助金额:
$ 34.37万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
- 批准号:
2881438 - 财政年份:2023
- 资助金额:
$ 34.37万 - 项目类别:
Studentship
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
$ 34.37万 - 项目类别:
Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
- 批准号:
MR/X005267/1 - 财政年份:2023
- 资助金额:
$ 34.37万 - 项目类别:
Research Grant














{{item.name}}会员




